Effectiveness of a novel, fixed dose combination of netupitant and palonosetron in prevention of chemotherapy induced nausea and vomiting: A real-life study from India

doi:10.5306/wjco.v11.i8.606

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6854)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

242

WORD

166

HTML

2317

Figures (1-1)

275

Tables (1-3)

325

Sum=3325

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

436

Download

1006

Sum=1442

Publishing Process of This Article

Item

Count

Browse

665

Download

1422

Sum=2087

Aug 24, 2020 (publication date) through Feb 18, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Oncol. Aug 24, 2020; 11(8): 606-613
Published online Aug 24, 2020. doi: 10.5306/wjco.v11.i8.606

Table 2 Outcome assessments

Population	Number of participants	Acute phase, Number of participants (%)	Delayed phase, Number of participants (%)	Overall phase, Number of participants (%)
Overall	403	397 (98.01)	378 (93.79)	378 (93.79)
Highly emetogenic chemotherapy	220	214 (97.27)	206 (93.63)	206 (93.63)
Moderately emetogenic chemotherapy	183	181 (98.90)	172 (93.98)	172 (93.98)

Complete response rate in acute delayed and overall phase among patients on highly and moderately emetogenic chemotherapy regimen.

Citation: Vaswani B, Bhagat S, Patil S, Barkate H. Effectiveness of a novel, fixed dose combination of netupitant and palonosetron in prevention of chemotherapy induced nausea and vomiting: A real-life study from India. World J Clin Oncol 2020; 11(8): 606-613
URL: https://www.wjgnet.com/2218-4333/full/v11/i8/606.htm
DOI: https://dx.doi.org/10.5306/wjco.v11.i8.606